ATE270331T1 - Rezeptor und dafür kodierendes nukleinsäuremolekül - Google Patents

Rezeptor und dafür kodierendes nukleinsäuremolekül

Info

Publication number
ATE270331T1
ATE270331T1 AT96938867T AT96938867T ATE270331T1 AT E270331 T1 ATE270331 T1 AT E270331T1 AT 96938867 T AT96938867 T AT 96938867T AT 96938867 T AT96938867 T AT 96938867T AT E270331 T1 ATE270331 T1 AT E270331T1
Authority
AT
Austria
Prior art keywords
nucleic acid
receptor
acid molecule
molecule coding
amino acid
Prior art date
Application number
AT96938867T
Other languages
English (en)
Inventor
Didier Communi
Sabine Pirotton
Marc Parmentier
Jean-Marie Boeynaems
Original Assignee
Euroscreen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euroscreen Sa filed Critical Euroscreen Sa
Application granted granted Critical
Publication of ATE270331T1 publication Critical patent/ATE270331T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT96938867T 1995-11-21 1996-11-21 Rezeptor und dafür kodierendes nukleinsäuremolekül ATE270331T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95870124 1995-11-21
PCT/BE1996/000123 WO1997019170A1 (en) 1995-11-21 1996-11-21 Receptor and nucleic acid molecule encoding said receptor

Publications (1)

Publication Number Publication Date
ATE270331T1 true ATE270331T1 (de) 2004-07-15

Family

ID=8222166

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96938867T ATE270331T1 (de) 1995-11-21 1996-11-21 Rezeptor und dafür kodierendes nukleinsäuremolekül

Country Status (8)

Country Link
US (5) US6790626B2 (de)
EP (2) EP1452600A1 (de)
JP (1) JP4439592B2 (de)
AT (1) ATE270331T1 (de)
CA (1) CA2235627C (de)
DE (1) DE69632830T2 (de)
DK (1) DK0862628T3 (de)
WO (1) WO1997019170A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2235627C (en) * 1995-11-21 2010-08-10 Euroscreen S.A. Receptor and nucleic acid molecule encoding said receptor
WO2000011170A1 (en) * 1998-08-20 2000-03-02 Millennium Pharmaceuticals, Inc. 14400 receptor, a g-protein coupled receptor
SE9804175D0 (sv) 1998-12-02 1998-12-02 Astra Pharma Prod New assay
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
WO2001036473A2 (en) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Human g protein-coupled receptors
EP1297140A2 (de) * 2000-06-26 2003-04-02 Bayer Aktiengesellschaft Regulation eines menschlichen p2y8-ähnlichen g-protein-gekoppelten rezeptors
EP1301792A2 (de) * 2000-07-07 2003-04-16 University Of North Carolina At Chapel Hill Verfahren und vorrichtung zur identifikation von p2y rezeptor agonisten und antagonisten
WO2005101003A1 (en) * 2004-04-13 2005-10-27 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with purinoceptor 4 type y (p2y4)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7965694A (en) 1993-10-15 1995-05-04 Curators Of The University Of Missouri, The Dna encoding the human p2u receptor and null cells expressing p2u receptors
US6008039A (en) 1995-06-02 1999-12-28 Incyte Pharmaceuticals, Inc. Polynucleotide encoding a novel purinergic P2U receptor
CA2235627C (en) * 1995-11-21 2010-08-10 Euroscreen S.A. Receptor and nucleic acid molecule encoding said receptor

Also Published As

Publication number Publication date
EP0862628B1 (de) 2004-06-30
EP1452600A1 (de) 2004-09-01
JP4439592B2 (ja) 2010-03-24
DE69632830T2 (de) 2005-08-25
EP0862628A1 (de) 1998-09-09
CA2235627A1 (en) 1997-05-29
CA2235627C (en) 2010-08-10
US20040175766A1 (en) 2004-09-09
JP2000503526A (ja) 2000-03-28
US20030082674A1 (en) 2003-05-01
US20040268426A1 (en) 2004-12-30
US7270966B2 (en) 2007-09-18
DK0862628T3 (da) 2004-11-01
US20040259171A1 (en) 2004-12-23
WO1997019170A1 (en) 1997-05-29
US20070044166A1 (en) 2007-02-22
US6790626B2 (en) 2004-09-14
US7312317B2 (en) 2007-12-25
DE69632830D1 (de) 2004-08-05

Similar Documents

Publication Publication Date Title
EP0977767A4 (de) Aminooxy-modifizierte oligonukleotide
DK1013661T3 (da) 2'-O,4'-metylen bicyklonukleosid
DE69719220D1 (de) Neue nucleotidanaloga
ATE239090T1 (de) Methode zum generieren von einzelsträngigen dna molekülen
DE69627698D1 (de) Eine in kaskaden verlaufende vervielfältigungsreaktion von nukleinsäuren
ATE265465T1 (de) Stabilisierte oligonucleotide und deren verwendung
DK0679657T3 (da) Nukleosider og oligonukleotider med 2'-ethergrupper
ATE277068T1 (de) 2'-modifizierte oligonucleotide mit rns wirkung, die konformell eingeschränkt sind
DK1104303T3 (da) Carbohydrat eller 2 ´ -modificerede oligonukleotider med alternerende internukleosidbindinger
ATE466948T1 (de) Dns-basiertes transposon-system für die einführung von nucleinsäure in die dns einer zelle
IL145497A0 (en) L-ribo-lna analogues
WO2002086088A3 (en) Polymerases with charge-switch activity and methods of generating such polymerases
HU9501963D0 (en) 7-deazapurine modified oligonucleotides
ATE321866T1 (de) Mutierte 5-enolpyruvylshikimat-3-phosphat synthase, für dieses protein kodierendes gen und dieses gen enthaltende transformierte pflanzen
AU6846798A (en) Method of nucleic acid sequencing
EP1063294A4 (de) Dns oder gene, die an der parkinsonschen krankheit beteiligt sind
DE69917636D1 (en) Polymerasesignalversuch
JP2001512666A5 (de)
ATE270331T1 (de) Rezeptor und dafür kodierendes nukleinsäuremolekül
EP1005539A4 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
DE69815370D1 (de) Fluoreszend-konjugaten von nukleosiden und von nukleotiden, ihrer verfahren zur herstellung und ihrer verwendungen
EP0769553A4 (de) Dna-fragment, rekombinanter vektor, der es enthält, und verfahren zur expression von fremdgenen mit seiner nutzung
HUP9801687A2 (hu) Eljárás nukleinsavak előállítására
AU2739797A (en) (in situ) preparation of nucleoside phosphoramidites and their use in synthesis of oligonucleotides
PL362475A1 (en) Dna sequence of the enzyme phospholipase a1 of ciliate tetrahymena, and the use of the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0862628

Country of ref document: EP

REN Ceased due to non-payment of the annual fee